Literature DB >> 24673154

Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus.

Edward Doherty1, Zachary Oaks, Andras Perl.   

Abstract

AIMS: Systemic lupus erythematosus (SLE) patients' peripheral blood lymphocytes (PBL) show mitochondrial dysfunction and oxidative stress. To determine the electrochemical bases of mitochondrial dysfunction, we measured electron transport chain (ETC) activity and its regulation by N-acetylcysteine (NAC) that reversed glutathione depletion and improved disease activity in SLE. ETC activity was assessed in PBL of 69 SLE patients and 37 healthy donors. Negatively isolated T cells were examined in 7 SLE patients, 11 healthy donors, and 10 nonlupus inflammatory arthritis (IA) donors.
RESULTS: O₂ consumption (in nmol/ml/min) by lupus PBL was increased at baseline (SLE: 2.492±0.196, control: 2.137±0.153; p=0.027) and with complex IV substrates (SLE: 7.722±0.419, control: 7.006±0.505; p=0.028). SLE PBL consumed more O₂ upon in-chamber T-cell activation (p=0.012). After overnight T-cell stimulation, ETC activity of SLE PBL was 2.27-fold increased through complex I (SLE: 1.606±0.273, control: 0.709±0.169; p=0.001) and, to a lesser extent, through complex IV. Likewise, complex I activity was elevated in negatively isolated "untouched" T cells of SLE patients (1.816±0.180) relative to healthy controls (0.917±0.094; p=0.0003) and IA disease controls studied in parallel (1.057±0.199; p=0.0308). NAC diminished O₂ consumption through complex I and H₂O₂ levels both in SLE and in control PBL. INNOVATION: O₂ consumption was found to be increased in SLE patients' PBL relative to control subjects evaluated in parallel. ETC complex I is identified as the main source of oxidative stress in SLE.
CONCLUSIONS: Lupus PBL exhibit increased O₂ consumption through mitochondrial ETC complex I that is inhibited by NAC, which may have therapeutic efficacy through reducing oxidative stress in SLE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24673154      PMCID: PMC4048573          DOI: 10.1089/ars.2013.5702

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  31 in total

1.  Discrimination of depolarized from polarized mitochondria by confocal fluorescence resonance energy transfer.

Authors:  Steven P Elmore; Yoshiya Nishimura; Ting Qian; Brian Herman; John J Lemasters
Journal:  Arch Biochem Biophys       Date:  2004-02-15       Impact factor: 4.013

2.  Topology of superoxide production from different sites in the mitochondrial electron transport chain.

Authors:  Julie St-Pierre; Julie A Buckingham; Stephen J Roebuck; Martin D Brand
Journal:  J Biol Chem       Date:  2002-09-16       Impact factor: 5.157

3.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

4.  Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.

Authors:  Enzo Nisoli; Emilio Clementi; Clara Paolucci; Valeria Cozzi; Cristina Tonello; Clara Sciorati; Renata Bracale; Alessandra Valerio; Maura Francolini; Salvador Moncada; Michele O Carruba
Journal:  Science       Date:  2003-02-07       Impact factor: 47.728

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells.

Authors:  B Sauter; M L Albert; L Francisco; M Larsson; S Somersan; N Bhardwaj
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

7.  Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.

Authors:  Gyorgy Nagy; Maureen Barcza; Nick Gonchoroff; Paul E Phillips; Andras Perl
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

8.  T cell activation-induced mitochondrial hyperpolarization is mediated by Ca2+- and redox-dependent production of nitric oxide.

Authors:  Gyorgy Nagy; Agnes Koncz; Andras Perl
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

9.  Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.

Authors:  Peter Gergely; Brian Niland; Nick Gonchoroff; Rudolf Pullmann; Paul E Phillips; Andras Perl
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

10.  Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.

Authors:  Peter Gergely; Craig Grossman; Brian Niland; Ferenc Puskas; Hom Neupane; Fatme Allam; Katalin Banki; Paul E Phillips; Andras Perl
Journal:  Arthritis Rheum       Date:  2002-01
View more
  36 in total

Review 1.  mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.

Authors:  Andras Perl
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

Review 2.  Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.

Authors:  Xiangyu Teng; Caleb Cornaby; Wei Li; Laurence Morel
Journal:  Curr Opin Immunol       Date:  2019-08-15       Impact factor: 7.486

Review 3.  Immune Cell Metabolism in Systemic Lupus Erythematosus.

Authors:  Seung-Chul Choi; Anton A Titov; Ramya Sivakumar; Wei Li; Laurence Morel
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.592

4.  Measurement of Mitochondrial Mass by Flow Cytometry during Oxidative Stress.

Authors:  Edward Doherty; Andras Perl
Journal:  React Oxyg Species (Apex)       Date:  2017-07-01

Review 5.  Metabolic determinants of lupus pathogenesis.

Authors:  Xiangyu Teng; Josephine Brown; Seung-Chul Choi; Wei Li; Laurence Morel
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 12.988

Review 6.  Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice.

Authors:  Kiley Bax; Paul J Isackson; Molly Moore; Julian L Ambrus
Journal:  Curr Rheumatol Rep       Date:  2020-02-14       Impact factor: 4.592

Review 7.  Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus.

Authors:  Junichi Fujii; Toshihiro Kurahashi; Tasuku Konno; Takujiro Homma; Yoshihito Iuchi
Journal:  World J Nephrol       Date:  2015-05-06

Review 8.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

9.  Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases.

Authors:  Ming Li; Wenjuan Gao; Jingjing Ma; Yun Zhu; Xingfu Li
Journal:  Exp Ther Med       Date:  2015-05-21       Impact factor: 2.447

10.  Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndrome.

Authors:  Zhi-wei Lai; Ivan Marchena-Mendez; Andras Perl
Journal:  Clin Immunol       Date:  2015-04-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.